| |
| |
|
| Insider
Information: |
Bobo Donald E Jr |
| Relationship: |
CVP,Strategy/Corp Deve... |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
46,936 |
|
|
Indirect Shares
|
173,767 |
|
|
| Direct
Value |
$1,373,164 |
|
|
|
Indirect Value
|
$5,083,745 |
|
|
| Total
Shares |
220,703 |
|
|
| Total
Value |
$6,456,909 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 105.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Edwards Lifesciences Corp |
EW |
CVP,Strategy/Corp Deve... |
2024-06-12 |
46,936 |
2024-06-12 |
173,767 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
326 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 14
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
• • – |
2014-10-03 |
4 |
OE |
$31.47 |
$786,750 |
D/D |
25,000 |
45,721 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
• – – |
2012-05-07 |
4 |
D |
$84.99 |
$72,921 |
D/D |
(858) |
46,278 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
• • – |
2016-09-02 |
4 |
AS |
$115.78 |
$2,084,049 |
D/D |
(18,000) |
46,901 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2024-05-11 |
4 |
D |
$86.72 |
$70,590 |
D/D |
(814) |
46,936 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2024-06-12 |
4 |
AS |
$87.54 |
$437,697 |
D/D |
(5,000) |
46,936 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
• – – |
2012-05-07 |
4 |
OE |
$13.01 |
$312,120 |
D/D |
24,000 |
47,136 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2023-12-13 |
4 |
OE |
$36.75 |
$294,000 |
D/D |
8,000 |
47,503 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2024-05-07 |
4 |
D |
$85.09 |
$52,671 |
D/D |
(619) |
47,750 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2024-05-10 |
4 |
AS |
$87.81 |
$439,038 |
D/D |
(5,000) |
47,750 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,700 |
48,369 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2020-08-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
24,324 |
48,508 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2020-08-14 |
4 |
AS |
$78.75 |
$1,029,605 |
D/D |
(13,074) |
48,508 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2020-09-11 |
4 |
AS |
$82.42 |
$1,077,988 |
D/D |
(13,074) |
48,508 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2020-10-09 |
4 |
AS |
$82.61 |
$1,079,997 |
D/D |
(13,074) |
48,508 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2020-11-13 |
4 |
AS |
$80.52 |
$1,053,260 |
D/D |
(13,074) |
48,508 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2020-12-11 |
4 |
AS |
$84.63 |
$1,106,699 |
D/D |
(13,074) |
48,508 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2021-01-08 |
4 |
AS |
$90.22 |
$1,182,756 |
D/D |
(13,077) |
48,508 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2021-02-05 |
4 |
AS |
$85.80 |
$1,121,996 |
D/D |
(13,077) |
48,508 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2021-03-12 |
4 |
AS |
$82.85 |
$1,083,375 |
D/D |
(13,077) |
48,508 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2021-04-09 |
4 |
AS |
$84.27 |
$1,102,046 |
D/D |
(13,077) |
48,845 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2024-01-12 |
4 |
OE |
$36.75 |
$367,500 |
D/D |
10,000 |
49,503 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
• – – |
2011-05-12 |
4 |
OE |
$18.26 |
$365,200 |
D/D |
20,000 |
49,990 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2021-05-11 |
4 |
D |
$90.40 |
$190,382 |
D/D |
(2,106) |
50,135 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP,Strategy/Corp Development |
• • – |
2024-02-13 |
4 |
OE |
$36.75 |
$404,250 |
D/D |
11,000 |
50,503 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Heart Valve Therapy |
• • – |
2014-10-24 |
4 |
OE |
$31.47 |
$944,100 |
D/D |
30,000 |
50,721 |
0 |
- |
|
326 Records found
|
|
Page 8 of 14 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
